The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: The VA Cooperative Study in diabetes

Journal of Diabetes and its Complications

Volumn 20, Issue 2, 2006, Pages 75-80

  Kirkman, M Sue ^a,b,i   McCarren, Madeline ^c   Shah, Jayendra ^d,e   Duckworth, William ^e,f   Abraira, Carlos ^g,h  

^a RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY   (United States)

^c HINES VA HOSPITAL   (United States)

^d SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f CARL T HAYDEN VA MEDICAL CENTER   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF MIAMI   (United States)

ⁱ EH 421 ^*  (United States)

Author keywords

Glycemic control; Macrovascular disease

Indexed keywords

ATORVASTATIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; ETHNOLOGY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INSULIN TREATMENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SMOKING; UNIVARIATE ANALYSIS; VASCULAR DISEASE;

BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; VASCULAR DISEASES;

EID: 33644558032     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2005.06.013     Document Type: Article

References (28)

1. C. Abraira, J. Colwell, F. Nuttall, C. Sawin, W. Henderson, J. Comstock, N. Emanuele, S. Levin, I. Pacold, and H.S. Lee Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II DM (VACSDM) Group: Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial Archives of Internal Medicine 157 1997 181 188
2. C. Abraira, W. Duckworth, M. McCaren, N. Emmanuele, D. Arca, D. Reda, and W. Henderson Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial Journal of Diabetes and its Complications 17 2003 314 322
3. H.P. Chase, W.E. Jackson, S.L. Hoops, R.S. Cockerham, P.G. Archer, and D. O'Brien Glucose control and the renal and retinal complications of insulin-dependent diabetes mellitus Journal of the American Medical Association 261 1989 1155 1160
4. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 18 1972 499 502
5. S. Geiss, W.H. Herman, and P.J. Smith Mortality in non-insulin-dependent diabetes M. Harris Diabetes in America/National Diabetes Data Group 2nd ed. 1995 National Institutes of Health Bethesda, MD 133 155
6. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction New England Journal of Medicine 339 1998 229 234
7. E.S. Huang, J.B. Meigs, and D.E. Singer The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus American Journal of Medicine 111 2001 633 642
8. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease: The Framingham Study Journal of the American Medical Association 241 1979 2035 2038
9. K.-T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day Association of hemoglobin A1c with cardiovascular disease and mortality in adults: The European Prospective Investigation into Cancer in Norfolk Annals of Internal Medicine 141 2004 413 420
10. R. Klein Hyperglycemia and microvascular and macrovascular disease in diabetes Diabetes Care 18 1995 258 268
11. R. Klein, B.E. Klein, S.E. Moss, and K.J. Cruikshanks Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy Archives of Internal Medicine 154 1994 2169 2178
12. M.W. Knuiman, T.A. Welborn, V.J. McCann, K.G. Stanton, and I.J. Constable Prevalence of diabetic complications in relation to risk factors Diabetes 35 1986 1332 1339
13. A.S. Krolewski, L.M.B. Laffel, M. Krolewski, M. Quinn, and J.H. Warram Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus New England Journal of Medicine 332 1995 1251 1255
14. J. Kuusisto, L. Mykkanen, K. Pyorala, and M. Laakso NIDDM and its metabolic control predict coronary heart disease in elderly subjects Diabetes 43 1994 960 967
15. M. Laakso Glycemic control and the risk of coronary heart disease in patients with non-insulin-dependent diabetes mellitus: The Finnish studies Annals of Internal Medicine 124(1S-II) Suppl. 1996 127 130
16. S.R. Levin, J.W. Coburn, C. Abraira, W.G. Henderson, J.A. Colwell, N.V. Emanuele, F.Q. Nuttall, C.T. Sawin, J.P. Comstock, C.K. Silbert for the VA Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators Effect of intensive glycemic control on microalbuminuria in type 2 diabetes Diabetes Care 23 2000 1478 1485
17. J.B. Meigs, D.E. Singer, L.M. Sullivan, K.A. Dukes, R.B. D'Agostino, D.M. Nathan, E.H. Wagner, S.H. Kaplan, and S. Greenfield Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcomes Research Team American Journal of Medicine 102 1997 38 47
18. Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, S. Motoyoshi, Y. Kojima, N. Furuyoshi, and M. Shichiri Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study Diabetes Research and Clinical Practice 28 1995 103 117
19. E. Selvin, S. Marinopolos, G. Berkenblit, T. Rami, F. Brancati, N. Powe, and S.H. Golden Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Annals of Internal Medicine 141 2004 421 431
20. D.E. Singer, D.M. Nathan, K.M. Anderson, P.W.F. Wilson, and J.C. Evans Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study Diabetes 41 1992 202 208
21. N.L. Smith, L. Chen, D.H. Au, M. McDonnell, and S.D. Fihn Cardiovascular risk factor control among veterans with diabetes Diabetes Care 27 Suppl. 2 2004 B33 B38
22. J. Stamler, O. Vaccaro, J.D. Neaton, and D. Wentworth Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 2 1993 434 444
23. I.M. Stratton, A.I. Adler, A.W. Neil, D.R. Matthews, S.E. Manley, C.A. Cull, D. Hadden, R.C. Turner, R.R. Holman the UK Prospective Diabetes Study Group Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) British Medical Journal 321 2000 405 412
24. The Diabetes Control and Complications Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus New England Journal of Medicine 329 1993 977 986
25. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) The Lancet 352 1998 837 853
26. UK Prospective Diabetes Study (UKPDS) Group Tight blood pressure control and risk of macrovascular and microvascular complications British Medical Journal 317 1998 703 713
27. S. Vijan, T. Hofer, and R. Hayward Estimated benefit from glycemic control in microvascular complications in type 2 diabetic patients Annals of Internal Medicine 127 1997 788 795
28. D.L. Wingard, and E. Barrett-Connor Heart disease and diabetes M. Harris Diabetes in America/National Diabetes Data Group 2nd ed. 1995 National Institutes of Health Bethesda, MD 429 448